Dimensional Fund Advisors’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Dimensional Fund Advisors’s Portfolio KRSA Stock Details KRSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.7K	Buy	+1,675	New	+$5.43K	﹤0.01%	3206
2022 Q2	–	Sell	-322	Closed	-$50K	–	3473
2022 Q1	$50K	Sell	322 -548	-63%	-$13.2K	﹤0.01%	3464
2021 Q4	$210K	Sell	870 -115	-12%	-$5.43K	﹤0.01%	3329
2021 Q3	$424K	Sell	985 -151	-13%	-$9.88K	﹤0.01%	3215
2021 Q2	$620K	Buy	1,136 +699	+160%	+$43.8K	﹤0.01%	3117
2021 Q1	$171K	Sell	437 -18	-4%	-$1.35K	﹤0.01%	3308
2020 Q4	$195K	Buy	455 +36	+9%	+$2.45K	﹤0.01%	3225
2020 Q3	$357K	Sell	419 -13	-3%	-$1.49K	﹤0.01%	3124
2020 Q2	$357K	Sell	432 -374	-46%	-$31.3K	﹤0.01%	3133
2020 Q1	$299K	Buy	806 +605	+301%	+$43.2K	﹤0.01%	3147
2019 Q4	$77K	Buy	+201	New	+$18.8K	﹤0.01%	3330
2019 Q3	–	Sell	-127	Closed	-$203K	–	3425
2019 Q2	$203K	Buy	+127	New	+$35.9K	﹤0.01%	3320

Other funds holding KRSA

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Dimensional Fund Advisors's KRSA Position: Q2 2026 in Review

Dimensional Fund Advisors opened a new position in Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2026: 1,675 shares worth $39.7K. The stake represents ﹤0.01% of the portfolio and ranks #3206 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in KRSA as recently as Q1 2022.

Dimensional Fund Advisors first reported a position in KRSA in Q2 2019 and has held it in 12 quarters since. The position peaked at $620K in Q2 2021. 21 funds tracked by Wall St. Rank hold KRSA as of Q2 2026.

Dimensional Fund Advisors held 1,675 shares of Korsana Biosciences, Inc. Common Stock worth $39.7K as of Q2 2026.
Korsana Biosciences, Inc. Common Stock was a new Dimensional Fund Advisors position in Q2 2026.
Korsana Biosciences, Inc. Common Stock made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3206 holding.
Dimensional Fund Advisors first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and has held it in 12 quarters since.
Dimensional Fund Advisors's Korsana Biosciences, Inc. Common Stock position peaked at $620K in Q2 2021.
21 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.